Wall St. Journal writes today: "GlaxoSmithKline has become the latest big pharma company to disclose payments to health-care providers, listing 3,700 U.S. doctors and others who received a total of $14.6 million in speaking and consulting fees during the second quarter."

Do the payments influence whether and which medicines doctors prescribe? Here's links to lists of some of the payments to doctors by three of America's biggest drugmakers:

GlaxoSmithKline: http://gsk-us.com/docs-pdf/responsibility/hcp-fee-disclosure-2q2009.pdf

Merck: http://www.merck.com/corporate-responsibility/docs/business-ethics-transparency/3Q09-Transparency-Report.pdf

Eli Lilly: http://www.lillyfacultyregistry.com/lilly-registry-report.jsp

More from the Journal here.